ICON Public Limited Company (ICLR) is a Medical - Diagnostics & Research company in the Healthcare sector, currently trading at $113.06. It has a SharesGrow Score of 71/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ICLR = $217.20 (+92.1% from the current price, the stock appears undervalued). Analyst consensus target is ICLR = $157 (+39.3% upside).
Valuation: ICLR trades at a trailing Price-to-Earnings (P/E) of 13.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.55.
Financials: revenue is $8.3B, +16%/yr average growth. Net income is $791M, growing at +93.4%/yr. Net profit margin is 9.6% (thin). Gross margin is 29.4% (+1.9 pp trend).
Balance sheet: total debt is $3.6B against $9.5B equity (Debt-to-Equity (D/E) ratio 0.38, conservative). Current ratio is 1.26 (adequate). Debt-to-assets is 21.3%. Total assets: $16.9B.
Analyst outlook: 17 / 30 analysts rate ICLR as buy (57%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 80/100 (Pass), Growth 90/100 (Pass), Past 100/100 (Pass), Health 67/100 (Partial), Moat 49/100 (Partial), Future 64/100 (Pass), Income 45/100 (Partial).
